FHTX

1.7203.37%
GR

Gerald R. Crabtree

Founder & Member of Scientific Advisory Board

Dr. Gerald R. Crabtree, M.D. serves as Member of Scientific Advisory Board at Foghorn Therapeutics Inc. He is Founder of Foghorn Therapeutics Inc. Dr. Crabtree is founder of Ariad Pharmaceuticals. Dr. Crabtree is Professor of Pathology and of Developmental Biology at Stanford University School of Medicine and a Howard Hughes Medical Institute Investigator. Dr. Crabtree served as a senior investigator at NIH before joining the Stanford faculty in 1985. His research is focused on genetic regulatory circuits controlling mammalian development. To modulate and understand these circuits, his laboratory is designing small molecules that activate or inhibit the products of specific genes critical to these circuits. He is a leading authority on calcineurin/NFAT signaling and the role of this pathway in the function and development of mammalian systems. He served as a Member of Scientific Advisory Board of Galenea Corp. He is a member of the National Academy of Sciences. He received his B.S. degree from West Liberty State College, West Virginia. After receiving his M.D. degree from Temple University School of Medicine, Dr. Crabtree performed postdoctoral work at Dartmouth Medical School.

Positions